PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation-Reference-Cited by-同舟云学术

PIK3CA-mutated melanoma cells rely on cooperative signaling through mTORC1/2 for sustained proliferation

Published:2017-04-20 Issue:3 Volume:30 Page:353-367
ISSN:1755-1471
Container-title:Pigment Cell & Melanoma Research
language:en
Short-container-title:Pigment Cell Melanoma Res.

Author:

Silva Jillian M.¹,Deuker Marian M.¹,Baguley Bruce C.²,McMahon Martin¹^ORCID

Affiliation:

1. Helen Diller Family Comprehensive Cancer Center; Department of Cellular & Molecular Pharmacology; University of California, San Francisco; San Francisco CA USA

2. Auckland Cancer Society Research Centre; School of Medical Sciences; University of Auckland; Auckland New Zealand

Funder

Institutional Research and Academic Career Development Award

National Cancer Institute

Melanoma Research Alliance

Publisher

Wiley

Subject

Dermatology,General Biochemistry, Genetics and Molecular Biology,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/pcmr.12586/fullpdf

Reference60 articles.

1. The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901;Barrett;Bioorg. Med. Chem. Lett.,2008

2. BRAF and RAS mutations in human lung cancer and melanoma;Brose;Cancer Res.,2002

3. Genomic classification of cutaneous melanoma;Cancer Genome Atlas Network;Cell,2015

4. PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3Kalpha inhibition;Castel;Cancer Cell,2016

5. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data;Cerami;Cancer Discov.,2012

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma;Biomedicines;2024-07-19

2. Neratinib, a pan ERBB/HER inhibitor, restores sensitivity of PTEN-null, BRAFV600E melanoma to BRAF/MEK inhibition;Frontiers in Oncology;2024-05-16

3. Actionable Mutation Profile of Sun-Protected Melanomas in South America;The American Journal of Dermatopathology;2022-05-04

4. The PIK3CA H1047R Mutation Confers Resistance to BRAF and MEK Inhibitors in A375 Melanoma Cells through the Cross-Activation of MAPK and PI3K–Akt Pathways;Pharmaceutics;2022-03-08

5. The role of PI3'‐lipid signalling in melanoma initiation, progression and maintenance;Experimental Dermatology;2021-11-09